MPWT
AQST icon

MassMutual Private Wealth & Trust’s Aquestive Therapeutics AQST Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64K Buy
875
+125
+17% +$526 ﹤0.01% 1792
2026
Q1 		$3.11K Buy
750
+175
+30% +$710 ﹤0.01% 1848
2025
Q4 		$3.71K Buy
+575
New +$3.58K ﹤0.01% 1804

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EAM
Everstar Asset Management Mooresville, North Carolina $207M AUM 18.14% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

MassMutual Private Wealth & Trust's AQST Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Aquestive Therapeutics (AQST) stake by 17% in Q2 2026, buying an estimated $526 and bringing the position to 875 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.

MassMutual Private Wealth & Trust first reported a position in AQST in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.71K in Q4 2025. 39 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • MassMutual Private Wealth & Trust held 875 shares of Aquestive Therapeutics worth $3.64K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 125 Aquestive Therapeutics shares in Q2 2026, an estimated $526.
  • Aquestive Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1792 holding.
  • MassMutual Private Wealth & Trust first reported a position in Aquestive Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • MassMutual Private Wealth & Trust's Aquestive Therapeutics position peaked at $3.71K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.